menu
    • menu

    Company profile for PolyPeptide Group

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-cert...
    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PolyPeptide GroupSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Neuhofstrasse 24 6340 Baar
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.polypeptide.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/polypeptide-group/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/PolypeptideG

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI India

    Not Confirmed

    envelop Contact Supplier

    CPhI India

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Over 500 million syringes of our hyaluronic acid have been safely used worldwide”

    mic“Over 500 million syringes of our hyaluronic acid have been safely used worldwide”

    This week, SpeakPharma interviews Marie-Armelle Floc’h, Chief of Quality and Regulatory Affairs at HTL Biotechnology, a global leader in the development and the manufacturing of pharmaceutical-grade biopolymers headquartered in Javené, Brittany (France). Since 1992, HTL has pioneered the production of hyaluronic acid (HA) through proprietary biofermentation, achieving unmatched purity and consistency for applications in ophthalmology, dermatology and rheumatology. Floc’h highlights how HTL Biotechnology’s compelling portfolio of pharmaceutical-grade biopolymers is built on uncompromising quality standards. These standards have enabled the company to supply biopolymers for over 30 years without a single batch recall, firmly establishing its reputation for reliability and excellence. She also discusses the inauguration of HTL Biotechnology’s new sterile hyaluronic acid production unit — a major milestone that reinforces the company’s leadership in biopolymer manufacturing and enables the development of innovative formulations combining hyaluronic acid with thermo-sensitive active ingredients. This new capability opens the door to advanced biomedical applications where safety, stability and efficacy must be preserved without compromising the integrity of delicate molecules and which requires the highest quality standards. What distinguishes HTL Biotechnology’s biopolymer platforms in the market today? HTL Biotechnology has built its reputation on delivering pharmaceutical‑grade biopolymers (hyaluronic acid, polynucleotides and recombinant collagen) with unmatched purity and consistency. Since its founding in 1992, the company has focused on premium quality positioning. With more than 30 years of experience, HTL Biotechnology guarantees pharmaceutical-grade biopolymers of exceptional purity and exemplary consistency to our clients. We have had no batch recalls in 30 years, a record that underlines the rigor and reliability embedded in our processes. This was made possible by our fully-integrated site in France, where R&D laboratories, GMP manufacturing, quality control, and regulatory expertise are brought together under one roof. Such integration allows us to support our clients seamlessly throughout their product development journey, from early innovation through to global commercialization.Also, the inauguration of our new sterile hyaluronic acid production unit expands the possibilities for our HA to be used in advanced formulations with thermo-sensitive active ingredients, while upholding the uncompromising quality that defines HTL Biotechnology.Our operations are guided by internationally recognized standards, including ISO 13485 certification, which ensures the quality and safety required by medical device manufacturers worldwide.In addition, our Halal certification provides our customers with a significant advantage in accessing and expanding into markets where these requirements are essential for commercialization.Beyond certifications, our commitment to supporting global growth is reflected in the Drug Master Files we maintain across five continents, enabling our clients to accelerate product registration and bring innovative therapies to markets across the world more efficiently. By combining craftsmanship with pharmaceutical rigor, supported by state-of-the-art equipment and advanced bio-production methods, we ensure that every batch produced not only meets the strictest standards, but also delivers the reliability and consistency needed across the entire healthcare ecosystem. HIGHLIGHTS// Biopolymers with unmatched purity/record of no batch recalls/integrated facility in France/operations guided by global standards/new sterile HA unit for advanced formulations  Navigating the complex and evolving regulatory frameworks across global markets can be challenging for healthcare companies. Can you tell us more about how HTL Biotechnology supports its partners in this area? Regulatory support is part of our core premium services offer. We provide pharmaceutical regulatory support to ensure products meet the necessary compliance standards, so our partners can focus on their growth. Our dedicated regulatory professionals bring global and regional expertise, with a team specifically supporting customers in Asia. We offer personalized assistance adapted to their products and to the compliance standards of the target market. This includes personalized case-management support for regulatory file submissions with the concerned health authorities to minimize risks of refusal or delay, with the aim of achieving approval quickly and smoothly.Our offer for regulatory support continues beyond approval. We continuously monitor updates to regulations and provide post-commercialization support to our partners to help them manage any necessary regulatory updates.HIGHLIGHTS// Regulatory support offered as premium service/global and regional expertise/personalized case management for faster approvals/continuous regulatory support  How does HTL Biotechnology integrate sustainability and corporate responsibility into its operations? Sustainability is embedded in HTL Biotechnology’s strategic vision and day-to-day operations. In 2024, the company renewed its commitment to environmental responsibility by reinforcing its corporate social responsibility (CSR) roadmap. Tangible progress was made across multiple fronts: a 27 percent reduction in greenhouse gas emissions per kilogram of HA produced between 2021 and 2024, and a 34 percent reduction in water consumption per kilogram of HA since 2020. In 2024, we renewed the ISO 14001:2015 certification for its environmental management system, reflecting rigorous audit protocols and continual improvement cycles. All employees have been trained in the ISO 14001-certified environmental management system, and 78 percent of critical suppliers have signed HTL Biotechnology’s Responsible Purchasing Charter.These results reflect HTL Biotechnology’s structured and proactive approach to reducing its environmental footprint while maintaining the highest standards of quality and compliance.HIGHLIGHTS// Sustainability embedded in strategic vision/strong CSR roadmap with measurable progress/reduction in greenhouse gas emissions/responsible sourcing 

    Impressions: 108

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/over-500-million-syringes-of-our-hyaluronic-acid-have-been-safely-used-worldwide

    PharmaCompass
    04 Nov 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaA Full-Service API CompanyA Full-Service API Company

    A Full-Service API Company
    A Full-Service API Company

    reelA Full-Service API Company

    This PharmaReel showcases ChemWerth, a full-service generic API company with over 40 years of experience, offering cGMP-quality APIs through 30+ manufacturing partners across the US, EU, India, and China, backed by 550+ global filings, and expertise in new product development, compliance, and logistics.

    Impressions: 159

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

    CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

    The contract development and manufacturing organization (CDMO) sector has emerged as a key partner in new drug development. This was evident from the strategic investments, partnerships, and expansions witnessed in the third quarter (Q3) of 2025. Several CDMOs, such as Cohance Lifesciences, Fermion Oy, Axplora, AGC Pharma Chemicals invested in new projects. Others, including Veranova, Aenova, and Biosynth, expanded capacities, while Ofichem strengthened its footprint with the acquisition of Avivia BV. CDMOs like Fareva, Evonik, and Samsung Biologics forged strategic partnerships for growth. During Q3, the sector continued to adopt artificial intelligence (AI). This prompted the US Food and Drug Administration (FDA) to issue guidance that recognizes the increasing use of AI and data analytics in drug development.  View CDMO Activity Tracker for Q3 2025 (Free Excel Available) Cohance, Veranova invest in bioconjugation suites in US; ChemExpress inks ADC deal Earlier this year, Indian drugmaker Suven Pharmaceuticals Limited merged with  leading CDMO Cohance Lifesciences Limited. The merged entity — Cohance Lifesciences — has invested US$ 10 million in a current Good Manufacturing Practice (cGMP) bioconjugation suite at its subsidiary NJ Bio in Princeton, New Jersey.  NJ Bio is executing a major program for an existing innovator client with multiple antibody-drug conjugate (ADC) candidates. Cohance also announced an INR 230 million (approximately US$ 2.58 million) investment in a cGMP oligonucleotide facility at its Hyderabad (India) site. Veranova’s Devens (Massachusetts) site successfully passed a routine FDA cGMP surveillance inspection with a “No Action Indicated” (NAI) classification. Earlier, the company had initiated a US$ 50 million investment to expand its ADC and bioconjugate capabilities at its Devens site. This includes a 9,000-square-foot facility expansion with a new process development lab, two additional cGMP suites, and state-of-the-art bioconjugation development and manufacturing capabilities. These initiatives strengthen the site’s highly potent API (HPAPI) and ADC development and manufacturing capabilities. Biosynth has expanded its Berlin facility with a new GMP bioconjugation suite. The expansion supports the company’s manufacturing capabilities in conjugate vaccines, conjugate drugs, activated polyethylene glycol (PEGs), and polymer-based drug delivery excipients. ChemExpress, Mabwell Bioscience, and Insilico Medicine have entered into a strategic partnership to jointly develop a large ADC compound library and advance next-generation ADC candidates. The collaboration combines Mabwell’s antibody and ADC technology, Insilico’s AI-powered drug design platform, and ChemExpress’s expertise in linker-payload chemistry. Together, they aim to build a complete, AI-driven ADC development model that accelerates discovery, optimization, and commercialization. This partnership is expected to enhance R&D efficiency and deliver safer, more effective cancer treatments.  View CDMO Activity Tracker for Q3 2025 (Free Excel Available) Fermion, Axplora, Aenova increase API manufacturing capacities; ICE Pharma expands India facility Finnish CDMO Fermion Oy has launched a renovation project at its Hanko (Finland) production site to modernize its API manufacturing capabilities. This expansion is part of Fermion's broader strategy to increase production, enhance flexibility in the manufacturing of both existing and future pharmaceutical products, and enable potential contract manufacturing opportunities. German CDMO Axplora has announced a €6.5 million (approximately US$ 7.5 million) investment to expand its API manufacturing capacity at its Vizag site in India. This expansion aims to strengthen both production capabilities and supply chain resilience. India-based Aarti Pharmalabs has inaugurated the first phase of its greenfield manufacturing facility in Gujarat (India). This expansion aims to bolster Aarti's CDMO and contract manufacturing organization (CMO) services, targeting a revenue goal of INR 10 billion (approximately US$ 112 million). Snapdragon Chemistry, which was acquired by Cambrex in 2023, has expanded its Massachusetts facility to better support peptide drug development and manufacturing. With this upgrade, the company can now handle peptide projects from early development through full-scale manufacturing. Italy-headquartered ICE Pharma has expanded its Raichem facility in India. The new facility will enhance the production of ursodeoxycholic acid (UDCA), an API it derives from chicken bile. This expansion increases the site’s raw UDCA output by 120 metric tons annually. Spain-headquartered AGC Pharma Chemicals inaugurated a new advanced manufacturing plant in Barcelona, with an investment of €110 million (approximately US$ 128.3 million). The plant spans 7,500 square meters and integrates cutting-edge technologies to support the entire drug development lifecycle — from R&D to commercial manufacturing. This represents a 30 percent increase in the company’s production capacity and introduces a segment dedicated to HPAPIs. Germany-headquartered Aenova has launched a new hot melt extrusion platform at its Regensburg (Germany) site. This new equipment enables the production of advanced drug formulations, while handling all testing and quality checks in-house. The move strengthens Aenova’s capabilities in developing and manufacturing complex medications. US-based Cytovance Biologics has introduced in-house formulation development services, enhancing its role as a comprehensive partner for biologic drug developers. These services utilize quality-by-design principles to ensure speed, safety, and precision in current and future client programs.  View CDMO Activity Tracker for Q3 2025 (Free Excel Available)  Ofichem acquires Avivia BV; Evonik, Samsung Biologics form strategic collaborations Europe-based CDMO Ofichem Group announced the acquisition of Avivia BV, a formulation development company in the Netherlands. This acquisition is part of Ofichem’s strategy to become a fully integrated provider of development solutions across both drug substance and drug product, with a focus on complex formulations. Ofichem has also acquired Meribel Pharma Solutions’ site in Uppsala (Sweden) to strengthen its support for biotech innovators and expand its presence in the Nordic region.  Simtra BioPharma Solutions has acquired a 65-acre property near its Bloomington, Indiana (US) facility, adding over 300,000 square feet of potential expansion space. With this site, Simtra now has the flexibility to rapidly expand in the US. German specialty chemicals company Evonik is partnering with German biotech Ethris to develop and commercialize a next-generation lipid nanoparticle (LNP) platform for delivering nucleic acid therapies. Evonik will assist in formulation using Ethris’ SNaP LNP technology. The LNP market alone is projected to grow to US$2.3 billion by 2032. Luxembourg-headquartered Fareva has partnered with Zhaoke Ophthalmology to expand its footprint in China’s pharma market. Zhaoke will act as Fareva’s go-to partner for customers seeking pharmaceutical manufacturing in China. Samsung Biologics has signed a 1.8 trillion won (US$ 1.3 billion) manufacturing agreement with an undisclosed US-based drugmaker. And UK-based eXmoor Pharma has partnered with Anthony Nolan to provide end-to-end services for cell therapy developers.  View CDMO Activity Tracker for Q3 2025 (Free Excel Available)  Our view The global CDMO market, valued at around US$ 255 billion in 2025, is projected to grow to over US$ 465 billion by 2032. Significantly, about 60 percent of new drug approvals in the US and over 65 percent in Europe now involve CDMO support. The developments outlined above underscore the increasing role CDMOs are playing today in bringing about growth and innovation in the pharmaceutical industry.  
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 2568

    https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

    #PharmaFlow by PHARMACOMPASS
    16 Oct 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Lifecore, PolyPeptide Partner on Peptide Manufacturing in U.S.
    Lifecore, PolyPeptide Partner on Peptide Manufacturing in U.S.

    28 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/28/3175225/23089/en/Lifecore-and-PolyPeptide-Announce-Collaboration-Intended-to-Offer-End-to-End-Peptide-Manufacturing-Solution-for-U-S-Market.html

    GLOBENEWSWIRE
    28 Oct 2025
    Share Share
    PolyPeptide Group Hits Major Milestone in Malmö Expansion
    PolyPeptide Group Hits Major Milestone in Malmö Expansion

    22 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-22/polypeptide-group-achieves-significant-milestone-in-malmoe-expansion-project

    PHARMAWEB
    22 Sep 2025
    Share Share
    PolyPeptide's H1 2025 Growth Surges 24%, Belgian Site Success
    PolyPeptide's H1 2025 Growth Surges 24%, Belgian Site Success

    12 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-12/polypeptide-delivers-plus24-growth-in-h1-2025-successful-ramp-up-at-its-belgian-site-2025-full-year

    PHARMAWEB
    12 Aug 2025
    Share Share
    Cytovance, PolyPeptide Collaborate On Peptide Drug Development
    Cytovance, PolyPeptide Collaborate On Peptide Drug Development

    13 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250113598664/en

    BUSINESSWIRE
    13 Jan 2025
    Share Share
    PolyPeptide Group Partners with Novavax on COVID-19 Vaccine
    PolyPeptide Group Partners with Novavax on COVID-19 Vaccine

    04 Jun 2020

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2020-06-04/polypeptide-group-partners-with-novavax-on-covid-19-vaccine/

    CONTRACTPHARMA
    04 Jun 2020
    Share Share
    Polypeptide Therapeutic Solutions and PMC Isochem sign business and technology collaboration agreement in the field of Cosmetic and Therapeutic Polypeptide.
    Polypeptide Therapeutic Solutions and PMC Isochem sign business and technology collaboration agreement in the field of Cosmetic and Therapeutic Polypeptide.

    12 Mar 2018

    // PRESS RELEASE

    http://pmcisochem.fr/sites/default/files/Polypeptide%20Therapeutic%20Solutions%20and%20PMC%20Isochem%20%20press%20release%20March%2012%202018%20NM.pdf

    PRESS RELEASE
    12 Mar 2018
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Leuprolide Acetate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Bio-Europe Autumn
    Not Confirmed
    arrow

    Leuprolide Acetate

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13150

    Submission : 1998-08-21

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2003-045 - Rev 00

    Issue Date : 2009-02-13

    Type : Chemical

    Substance Number : 1442

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 231MF10082

    Registrant's Address : Ho(¨)gerudsgatan 21, Limhamn

    Initial Date of Registration : 2019-04-03

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2025-10-24

    Valid Till : 2028-10-23

    Written Confirmation Number : WC-0047

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 59149-002

    Start Marketing Date : 2023-04-03

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (100g/100g)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Daewoong Pharmaceutical Co., Ltd.

    Registration Date : 2019-04-15

    Registration Number : 20170725-210-J-1(A)

    Manufacturer Name : PolyPeptide Laboratories Pvt. Ltd.

    Manufacturer Address : Plot No K28, Additional MIDC, Anandnagar Ambernath(E) Thane 421506 Maharashtra state, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Desmopressin Acetate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Bio-Europe Autumn
    Not Confirmed
    arrow

    Desmopressin Acetate

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 8396

    Submission : 1990-01-26

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2006-266 - Rev 00

    Issue Date : 2013-11-27

    Type : Chemical and TSE

    Substance Number : 712

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 306MF10047

    Registrant's Address : Ho(¨)gerudsgatan 21, Limhamn

    Initial Date of Registration : 2024-03-27

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 63586-0115

    Start Marketing Date : 2017-09-25

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (4g/4g)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Meditip Co., Ltd.

    Registration Date : 2022-03-08

    Registration Number : 20220308-209-J-1247

    Manufacturer Name : PolyPeptide Laboratories (Sweden) AB

    Manufacturer Address : Högerudsgatan 21, Limhamn, 216 13, Sweden

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Exenatide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Bio-Europe Autumn
    Not Confirmed
    arrow

    Exenatide

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 19646

    Submission : 2006-07-31

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 223MF10041

    Registrant's Address : Chausse(')e de Tubize 297, Braine-L'Alleud, 1420, Belgium

    Initial Date of Registration : 2011-03-10

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2025-10-24

    Valid Till : 2028-10-23

    Written Confirmation Number : WC-0047

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 59149-004

    Start Marketing Date : 2023-02-20

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (250g/250g)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Meditip Co., Ltd.

    Registration Date : 2022-04-28

    Registration Number : Su233-2-ND

    Manufacturer Name : PolyPeptide Laboratories Pvt. Ltd.

    Manufacturer Address : Plot No K28, Additional MIDC, Anandnagar Ambernath(E) Thane 421506 Maharashtra state, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Octreotide Acetate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Bio-Europe Autumn
    Not Confirmed
    arrow

    Octreotide Acetate

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 14994

    Submission : 2000-08-04

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2021-279 - Rev 00

    Issue Date : 2022-04-29

    Type : Chemical

    Substance Number : 2414

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2025-10-24

    Valid Till : 2028-10-23

    Written Confirmation Number : WC-0047

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 59149-007

    Start Marketing Date : 2023-02-20

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (6g/6g)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Meditip Co., Ltd.

    Registration Date : 2022-07-11

    Registration Number : 20220711-210-J-1331

    Manufacturer Name : PolyPeptide Laboratories Pvt. Ltd

    Manufacturer Address : Plot No. K28, Addtional MIDC, Anandnagar, Ambernath(E), Thane 421 506, Maharashtra State, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Desmopressin Acetate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Bio-Europe Autumn
    Not Confirmed
    arrow

    Desmopressin Acetate

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 16813

    Submission : 2003-09-03

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2000-142 - Rev 04

    Issue Date : 2010-02-12

    Type : Chemical and TSE

    Substance Number : 712

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 224MF10122

    Registrant's Address : Ho(¨)gerudsgatan 21, Limhamn

    Initial Date of Registration : 2012-07-09

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 63586-0005

    Start Marketing Date : 1982-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1g/g)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Korea Ferring Pharmaceutical Co., Ltd.

    Registration Date : 2022-01-05

    Registration Number : 20220105-209-J-1192

    Manufacturer Name : PolyPeptide Laboratories (Sweden) AB

    Manufacturer Address : Högerudsgatan 21, Limhamn, 216 13, Sweden

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Corticotropin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Bio-Europe Autumn
    Not Confirmed
    arrow

    Corticotropin

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 21473

    Submission : 2008-03-28

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2025-10-24

    Valid Till : 2028-10-23

    Written Confirmation Number : WC-0047

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 59149-005

    Start Marketing Date : 2023-04-11

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (350g/350g)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Felypressin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Bio-Europe Autumn
    Not Confirmed
    arrow

    Felypressin

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2011-247 - Rev 01

    Issue Date : 2018-11-05

    Type : Chemical

    Substance Number : 1634

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 220MF10039

    Registrant's Address : Ho(¨)gerudsgatan 21, Limhamn

    Initial Date of Registration : 2008-02-05

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 63586-0123

    Start Marketing Date : 2018-09-14

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (0.2g/.2g)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Leuprolide Acetate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Bio-Europe Autumn
    Not Confirmed
    arrow

    Leuprolide Acetate

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-03-31

    Pay. Date : 2013-02-28

    DMF Number : 26832

    Submission : 2013-02-20

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2011-321 - Rev 02

    Issue Date : 2023-01-26

    Type : Chemical

    Substance Number : 1442

    Status : Valid

     JDMF EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : BC World Pharmaceutical Co., Ltd.

    Registration Date : 2017-12-08

    Registration Number : 20170725-210-J-1(1)

    Manufacturer Name : PolyPeptide Laboratories Pvt. Ltd.

    Manufacturer Address : Plot No K28, Additional MIDC, Anandnagar Ambernath(E) Thane 421506 Maharashtra state, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Somatostatin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Bio-Europe Autumn
    Not Confirmed
    arrow

    Somatostatin

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2010-169 - Rev 03

    Issue Date : 2022-09-27

    Type : Chemical

    Substance Number : 949

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2025-10-24

    Valid Till : 2028-10-23

    Written Confirmation Number : WC-0047

    Address of the Firm :

    NDC KDMF arrow-down
    ✖

    Registrant Name : Leaders Bio Co., Ltd.

    Registration Date : 2022-09-28

    Registration Number : 20171030-90-E-135-03(A)

    Manufacturer Name : PolyPeptide Laboratories PVT. LTD.

    Manufacturer Address : Plot No K28, Additional MIDC, Anandnagar, Ambernath(E) Thane 421506, Maharashtra State, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Teriparatide Acetate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Bio-Europe Autumn
    Not Confirmed
    arrow

    Teriparatide Acetate

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2015-07-29

    Pay. Date : 2015-04-01

    DMF Number : 22322

    Submission : 2008-12-16

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 230MF10022

    Registrant's Address : 365 Maple Avenue, Torrance, CA 90503, U.S. S. A

    Initial Date of Registration : 2018-02-14

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Korea BMI Co., Ltd.

    Registration Date : 2019-06-24

    Registration Number : Su434-6-ND(1)

    Manufacturer Name : PolyPeptide Laboratories, Inc.

    Manufacturer Address : 365 Maple Avenue Torrance, CA 90503, USA

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    USDMF

    read-more
    read-more

    01

    Acyline

    U.S.A
    Bio-Europe Autumn
    Not Confirmed
    arrow

    02

    Alpha-corticotropin (1-24) Acetate

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    03

    Antocin

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    04

    Bivalirudin (tm-001-2g)

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    05

    Calcitonin (salmon)

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    06

    Calcitonin (salmon), Ph.eur.

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    07

    Deslorelin Acetate

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    08

    Desmopressin

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    09

    Desmopressin (acetate) (code Sf278)

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    10

    Desmopressin Acetate Drug Substance

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Calcitonin (salmon), Synthetic Origin

    CEP/COS

    Bio-Europe Autumn
    Not Confirmed
    arrow

    02

    Desmopressin, 40001

    CEP/COS

    Bio-Europe Autumn
    Not Confirmed
    arrow

    03

    Desmopressin, 41006

    CEP/COS

    Bio-Europe Autumn
    Not Confirmed
    arrow

    04

    Desmopressin, Liquid phase synthesis pro...

    CEP/COS

    Bio-Europe Autumn
    Not Confirmed
    arrow

    05

    Felypressin

    CEP/COS

    Bio-Europe Autumn
    Not Confirmed
    arrow

    06

    Leuprorelin

    CEP/COS

    Bio-Europe Autumn
    Not Confirmed
    arrow

    07

    Leuprorelin, Process F

    CEP/COS

    Bio-Europe Autumn
    Not Confirmed
    arrow

    08

    Octreotide

    CEP/COS

    Bio-Europe Autumn
    Not Confirmed
    arrow

    09

    Somatostatin

    CEP/COS

    Bio-Europe Autumn
    Not Confirmed
    arrow

    10

    Somatostatin, F

    CEP/COS

    Bio-Europe Autumn
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    LISTED APIs

    read-more
    read-more
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Atosiban

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all cu...
    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.
    blank

    01

    Atosiban

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    Atosiban

    Switzerland
    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PolyPeptide Group

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.

    About the Company : PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmace...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Calcitonin

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all cu...
    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.
    blank

    02

    Calcitonin

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    Calcitonin

    Switzerland
    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PolyPeptide Group

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.

    About the Company : PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmace...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Corticotropin

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all cu...
    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.
    blank

    03

    Corticotropin

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    Corticotropin

    Switzerland
    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PolyPeptide Group

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.

    About the Company : PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmace...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Deslorelin

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all cu...
    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.
    blank

    04

    Deslorelin

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    Deslorelin

    Switzerland
    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PolyPeptide Group

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.

    About the Company : PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmace...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Desmopressin

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all cu...
    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.
    blank

    05

    Desmopressin

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    Desmopressin

    Switzerland
    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PolyPeptide Group

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.

    About the Company : PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmace...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Exenatide

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all cu...
    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.
    blank

    06

    Exenatide

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    Exenatide

    Switzerland
    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PolyPeptide Group

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.

    About the Company : PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmace...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Felypressin

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all cu...
    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.
    blank

    07

    Felypressin

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    Felypressin

    Switzerland
    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PolyPeptide Group

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.

    About the Company : PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmace...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Leuprolide

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all cu...
    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.
    blank

    08

    Leuprolide

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    Leuprolide

    Switzerland
    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PolyPeptide Group

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.

    About the Company : PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmace...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Liraglutide

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all cu...
    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.
    blank

    09

    Liraglutide

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    Liraglutide

    Switzerland
    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PolyPeptide Group

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.

    About the Company : PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmace...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Octreotide

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all cu...
    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.
    blank

    10

    Octreotide

    Switzerland
    Bio-Europe Autumn
    Not Confirmed
    arrow

    Octreotide

    Switzerland
    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PolyPeptide Group

    PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1000 employees, its diversity brings breadth, depth of knowledge and experience to the group.

    About the Company : PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmace...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Drugs in Development

    read-more
    read-more
    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PolyPeptide Group Partners with Novavax on COVID-19 Vaccine

    Details:

    PolyPeptide will produce 2 key intermediates used in the production of Matrix-M to enhance the vaccine’s immune response and stimulate high levels of neutralizing antibodies. NVX-CoV2373 is a stable, prefusion protein made using Novavax’ proprietary nanoparticle technology.


    Lead Product(s): NVX-COV2373,COVID-19 Vaccine, Adjuvanted,Matrix-M

    Therapeutic Area: Infections and Infectious Diseases Brand Name: Nuvaxovid

    Study Phase: Phase IProduct Type: Vaccine

    Sponsor: Novavax

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership June 04, 2020

    blank

    01

    PolyPeptide Group

    Switzerland
    arrow
    Bio-Europe Autumn
    Not Confirmed

    PolyPeptide Group

    Switzerland
    arrow
    Bio-Europe Autumn
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : NVX-COV2373,COVID-19 Vaccine, Adjuvanted,Matrix-M

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Phase I

    Partner/Sponsor/Collaborator : Novavax

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    PolyPeptide Group Partners with Novavax on COVID-19 Vaccine

    Details : PolyPeptide will produce 2 key intermediates used in the production of Matrix-M to enhance the vaccine’s immune response and stimulate high levels of neutralizing antibodies. NVX-CoV2373 is a stable, prefusion protein made using Novavax’ proprietary...

    Product Name : Nuvaxovid

    Product Type : Vaccine

    Upfront Cash : Undisclosed

    June 04, 2020

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Services

    Upload your portfolio for free, ask us

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact PolyPeptide Laboratories Sweden AB and get a quotation

    PolyPeptide Laboratories Sweden AB is a supplier offers 57 products (APIs, Excipients or Intermediates).

    Find a price of Leuprolide Acetate bulk with DMF, CEP, JDMF, WC offered by PolyPeptide Laboratories Sweden AB

    Find a price of Desmopressin Acetate bulk with DMF, CEP, JDMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Exenatide bulk with DMF, JDMF, WC offered by PolyPeptide Laboratories Sweden AB

    Find a price of Octreotide Acetate bulk with DMF, CEP, WC offered by PolyPeptide Laboratories Sweden AB

    Find a price of Desmopressin Acetate bulk with CEP, JDMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Corticotropin bulk with DMF, WC offered by PolyPeptide Laboratories Sweden AB

    Find a price of Felypressin bulk with CEP, JDMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Leuprolide Acetate bulk with DMF, CEP offered by PolyPeptide Laboratories Sweden AB

    Find a price of Somatostatin bulk with CEP, WC offered by PolyPeptide Laboratories Sweden AB

    Find a price of Teriparatide Acetate bulk with DMF, JDMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Calcitonin bulk with CEP offered by PolyPeptide Laboratories Sweden AB

    Find a price of Desmopressin Acetate bulk with DMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Octreotide Acetate bulk with WC offered by PolyPeptide Laboratories Sweden AB

    Find a price of Terlipressin Acetate bulk with CEP offered by PolyPeptide Laboratories Sweden AB

    Find a price of Arginine Vasopressin bulk with DMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Calcitonin bulk with DMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Deslorelin bulk with DMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Deslorelin Acetate bulk with WC offered by PolyPeptide Laboratories Sweden AB

    Find a price of Difelikefalin Acetate bulk with JDMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Eptifibatide bulk with DMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Exenatide bulk with DMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Glepaglutide bulk with DMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Gonadorelin Acetate bulk with JDMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Icatibant Acetate bulk with WC offered by PolyPeptide Laboratories Sweden AB

    Find a price of Linaclotide bulk with DMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Liraglutide bulk with DMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Octreotide Acetate bulk with DMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Secretin bulk with DMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Semaglutide bulk with DMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Terlipressin Acetate bulk with DMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Tertomotide bulk with DMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Thymalfasin bulk with DMF offered by PolyPeptide Laboratories Sweden AB

    Find a price of Triptorelin Pamoate bulk with WC offered by PolyPeptide Laboratories Sweden AB

    Find a price of Arginine Vasopressin bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Atosiban bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Bivalirudin bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Eptifibatide bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Pramlintide bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Secretin bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Sinapultide bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Somatostatin bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL AND OPERATING PROCEDURES IN HILLEROD, DENMARK bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Abaloparatide bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Angiotensin II bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Degarelix Acetate bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Leuprolide Acetate bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Macimorelin Acetate bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Motixafortide bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Setmelanotide Acetate bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Teduglutide bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Teriparatide bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Teriparatide Acetate bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Tetracosactide bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of Zilucoplan Sodium bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of ETEPLIRSEN bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of GONADOTROPIN HYDROCHLORIDE bulk offered by PolyPeptide Laboratories Sweden AB

    Find a price of NERINETIDE HYDROCHLORIDE bulk offered by PolyPeptide Laboratories Sweden AB

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search